Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy.

Yao, Yongrong; Chen, Huachao; Tan, Ninghua

Yao, Yongrong; Chen, Huachao; Tan, Ninghua.

Afiliación

Yao Y; State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Chen H; State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Tan N; State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.

Acta Pharm Sin B ; 12(4): 2103-2119, 2022 Apr.

Article en En | MEDLINE | ID: mdl-35847496

Palabras clave

Antitumor immune response; Cancer-cell-biomimetic nanoparticles; Checkpoint blockade-based immunotherapy; Chemotherapy; Combination therapy nanosystem; Cyclopeptide RA-V; PD-1/PD-L1 pathway; Synergetic mechanism

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Acta Pharm Sin B Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google